FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2612908045> ?p ?o ?g. }

• W2612908045 endingPage "3493" @default.
• W2612908045 startingPage "3486" @default.
• W2612908045 abstract "BACKGROUND As systemic therapy has improved for locally advanced pancreatic cancer (LAPC), efforts to improve local control with optimal radiotherapy may be critical. Although conventionally fractionated radiation therapy (CFRT) has more recently shown a limited role in LAPC, stereotactic body radiation therapy (SBRT) is an emerging approach with promising results. With no studies to date comparing SBRT with CFRT for LAPC, this study used the National Cancer Data Base (NCDB) to evaluate these 2 modalities. METHODS With the NCDB, patients with American Joint Committee on Cancer cT2‐4/N0‐1/M0 adenocarcinoma of the pancreas diagnosed from 2004 to 2013 were analyzed. Radiation therapy delivered at ≤2 Gy was deemed CFRT, and radiation therapy delivered at ≥4 Gy per fraction was considered SBRT. Kaplan‐Meier analysis, log‐rank testing, and multivariate Cox proportional hazards regression were performed with overall survival (OS) as the primary outcome. Propensity score matching was used. RESULTS Among 8450 patients, 7819 (92.5%) were treated with CFRT, and 631 (7.5%) underwent SBRT. Receipt of SBRT was associated with superior OS in the multivariate analysis (hazard ratio, 0.84; 95% confidence interval, 0.75‐0.93; P < .001). With propensity score matching, 988 patients in all were matched, with 494 patients in each cohort. Within the propensity‐matched cohorts, the median OS (13.9 vs 11.6 months) and the 2‐year OS rate (21.7% vs 16.5%) were significantly higher with SBRT versus CFRT ( P = .0014). CONCLUSIONS In this retrospective review using a large national database, SBRT was associated with superior OS in comparison with CFRT for LAPC, and these findings remained significant in a propensity‐matched analysis. Further prospective studies investigating these hypothesis‐generating results are warranted. Cancer 2017;123:3486‐93. © 2017 American Cancer Society ." @default.
• W2612908045 created "2017-05-19" @default.
• W2612908045 creator A5006174923 @default.
• W2612908045 creator A5023129222 @default.
• W2612908045 creator A5024852113 @default.
• W2612908045 creator A5025069842 @default.
• W2612908045 creator A5029089899 @default.
• W2612908045 creator A5043541884 @default.
• W2612908045 creator A5056296628 @default.
• W2612908045 creator A5065088834 @default.
• W2612908045 creator A5088349842 @default.
• W2612908045 date "2017-05-10" @default.
• W2612908045 modified "2023-10-17" @default.
• W2612908045 title "Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation" @default.
• W2612908045 cites W1563283949 @default.
• W2612908045 cites W1965404729 @default.
• W2612908045 cites W1972054401 @default.
• W2612908045 cites W1974219858 @default.
• W2612908045 cites W1987879195 @default.
• W2612908045 cites W2012658469 @default.
• W2612908045 cites W2016236483 @default.
• W2612908045 cites W2023048269 @default.
• W2612908045 cites W2033002476 @default.
• W2612908045 cites W2047318784 @default.
• W2612908045 cites W2061142163 @default.
• W2612908045 cites W2067072061 @default.
• W2612908045 cites W2087647994 @default.
• W2612908045 cites W2091193950 @default.
• W2612908045 cites W2103711657 @default.
• W2612908045 cites W2119914737 @default.
• W2612908045 cites W2121257623 @default.
• W2612908045 cites W2146974261 @default.
• W2612908045 cites W2151253787 @default.
• W2612908045 cites W2164019557 @default.
• W2612908045 cites W2164498941 @default.
• W2612908045 cites W2165480504 @default.
• W2612908045 cites W2335313798 @default.
• W2612908045 cites W2346921980 @default.
• W2612908045 cites W2403094648 @default.
• W2612908045 cites W2440631136 @default.
• W2612908045 cites W2501135239 @default.
• W2612908045 cites W4232739392 @default.
• W2612908045 cites W4247785462 @default.
• W2612908045 cites W4253769310 @default.
• W2612908045 cites W4253922044 @default.
• W2612908045 cites W4290357395 @default.
• W2612908045 doi "https://doi.org/10.1002/cncr.30706" @default.
• W2612908045 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5589506" @default.
• W2612908045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28493288" @default.
• W2612908045 hasPublicationYear "2017" @default.
• W2612908045 type Work @default.
• W2612908045 sameAs 2612908045 @default.
• W2612908045 citedByCount "98" @default.
• W2612908045 countsByYear W26129080452016 @default.
• W2612908045 countsByYear W26129080452017 @default.
• W2612908045 countsByYear W26129080452018 @default.
• W2612908045 countsByYear W26129080452019 @default.
• W2612908045 countsByYear W26129080452020 @default.
• W2612908045 countsByYear W26129080452021 @default.
• W2612908045 countsByYear W26129080452022 @default.
• W2612908045 countsByYear W26129080452023 @default.
• W2612908045 crossrefType "journal-article" @default.
• W2612908045 hasAuthorship W2612908045A5006174923 @default.
• W2612908045 hasAuthorship W2612908045A5023129222 @default.
• W2612908045 hasAuthorship W2612908045A5024852113 @default.
• W2612908045 hasAuthorship W2612908045A5025069842 @default.
• W2612908045 hasAuthorship W2612908045A5029089899 @default.
• W2612908045 hasAuthorship W2612908045A5043541884 @default.
• W2612908045 hasAuthorship W2612908045A5056296628 @default.
• W2612908045 hasAuthorship W2612908045A5065088834 @default.
• W2612908045 hasAuthorship W2612908045A5088349842 @default.
• W2612908045 hasBestOaLocation W26129080451 @default.
• W2612908045 hasConcept C121608353 @default.
• W2612908045 hasConcept C126322002 @default.
• W2612908045 hasConcept C126838900 @default.
• W2612908045 hasConcept C143998085 @default.
• W2612908045 hasConcept C155806632 @default.
• W2612908045 hasConcept C167135981 @default.
• W2612908045 hasConcept C17923572 @default.
• W2612908045 hasConcept C207103383 @default.
• W2612908045 hasConcept C2780210213 @default.
• W2612908045 hasConcept C2780387249 @default.
• W2612908045 hasConcept C2989005 @default.
• W2612908045 hasConcept C44249647 @default.
• W2612908045 hasConcept C50382708 @default.
• W2612908045 hasConcept C509974204 @default.
• W2612908045 hasConcept C71924100 @default.
• W2612908045 hasConcept C72563966 @default.
• W2612908045 hasConceptScore W2612908045C121608353 @default.
• W2612908045 hasConceptScore W2612908045C126322002 @default.
• W2612908045 hasConceptScore W2612908045C126838900 @default.
• W2612908045 hasConceptScore W2612908045C143998085 @default.
• W2612908045 hasConceptScore W2612908045C155806632 @default.
• W2612908045 hasConceptScore W2612908045C167135981 @default.
• W2612908045 hasConceptScore W2612908045C17923572 @default.
• W2612908045 hasConceptScore W2612908045C207103383 @default.
• W2612908045 hasConceptScore W2612908045C2780210213 @default.
• W2612908045 hasConceptScore W2612908045C2780387249 @default.

• next